About Tonghua Dongbao Pharmaceutical
Tonghua Dongbao Pharma develops and markets recombinant human insulin for the treatment of diabetes.
Key Facts
- Industry
- Finance & Banking
- Founded
- 1985
- Headquarters
- Tonghua, Shanxi, China
- Company size
- 251-500 employees
- Website
- thdb.com
- Operating status
- Active
- Phone
- 0435-5088008
- Legal Name
- Tonghua Dongbao Pharmaceutical Co., Ltd.
- Company Type
- For Profit
- Last Funding Type
- Post-IPO Equity
- Stock Symbol
- SSE:600867
- Last Investment Activity
- May 8, 2024
- Investments Activity
- May 8, 2024, Sep 10, 2020, Apr 14, 2017
- Phone Number
- 0435-5088008
Key employees
No employees found in our database.
General Emails
General company emails, e.g. customer support lines
Similar Companies like Tonghua Dongbao Pharmaceutical
Blackstone Group
HQ: New York, NY
BMO Nesbitt Burns
HQ: Toronto, Ontario, Canada
Team8
HQ: Tel Aviv-yafo, Tel Aviv, Israel
Sequoia Capital
HQ: Menlo Park, California, United States
BMO Capital Markets
HQ: Toronto, Ontario, Canada
Frequently Asked Questions about Tonghua Dongbao Pharmaceutical
What does Tonghua Dongbao Pharmaceutical do?
Tonghua Dongbao Pharma develops and markets recombinant human insulin for the treatment of diabetes.
Where is Tonghua Dongbao Pharmaceutical headquartered?
Tonghua Dongbao Pharmaceutical is headquartered in Tonghua, Shanxi, China.
When was Tonghua Dongbao Pharmaceutical founded?
Tonghua Dongbao Pharmaceutical was founded in 1985.
How many employees does Tonghua Dongbao Pharmaceutical have?
Tonghua Dongbao Pharmaceutical has approximately 251-500 employees.
What industry is Tonghua Dongbao Pharmaceutical in?
Tonghua Dongbao Pharmaceutical operates in the Finance & Banking industry.
How do I contact Tonghua Dongbao Pharmaceutical?
You can contact Tonghua Dongbao Pharmaceutical via email at info@thdb.com or admin@thdb.com, headquartered in Tonghua, Shanxi, China.